Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Daiichi Sankyo
Baxter
Merck
Citi
Express Scripts
Julphar
Covington

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Elotuzumab

« Back to Dashboard

US Patents for Elotuzumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Elotuzumab ➤ Try a Free Trial Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) ➤ Try a Free Trial
Elotuzumab ➤ Try a Free Trial Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies Celgene Corporation (Summit, NJ) ➤ Try a Free Trial
Elotuzumab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Elotuzumab ➤ Try a Free Trial Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts Advenchen Pharmaceuticals, LLC (Moorpark, CA) ➤ Try a Free Trial
Elotuzumab ➤ Try a Free Trial P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial
Elotuzumab ➤ Try a Free Trial Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial
Elotuzumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Elotuzumab

Drugname Country Document Number Estimated Expiration Related US Patent
Elotuzumab Australia 2015341301 2034-10-30 ➤ Try a Free Trial
Elotuzumab Canada 2966038 2034-10-30 ➤ Try a Free Trial
Elotuzumab China 105566290 2034-10-30 ➤ Try a Free Trial
Elotuzumab European Patent Office 3214081 2034-10-30 ➤ Try a Free Trial
Elotuzumab Japan 2017533955 2034-10-30 ➤ Try a Free Trial
Elotuzumab South Korea 20170078740 2034-10-30 ➤ Try a Free Trial
Elotuzumab World Intellectual Property Organization (WIPO) 2016065980 2034-10-30 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
McKesson
Cerilliant
Fish and Richardson
Queensland Health
Chubb
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.